Amgen Inc. Expands Manufacturing Operations with a $1 Billion Investment in North Carolina
Published on December 8, 2024
Amgen Inc., a leading biotechnology company, has announced plans to invest $1 billion in expanding its manufacturing operations in North Carolina. The investment aims to increase the company's production capacity and meet the growing demand for its innovative therapies. This expansion will create hundreds of new jobs in the region, providing a boost to the local economy. Amgen's commitment to expanding its manufacturing capabilities highlights its confidence in its product pipeline and its dedication to providing life-saving medications to patients worldwide.
Investor opinions & comments
To leave a comment, you need to Login or Register.
There are no comments yet. Be the first to leave one!